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Abstract
Introduction: To prospectively evaluate the performance of Lipopolysaccharide-Binding Protein (LBP) in prediction of
hospital mortality and its correlation to C-reactive Protein (CRP), we studied sixty consecutive, postoperative patients with
sepsis admitted to the university hospital intensive care unit.
Measurements and Methods: Plasma LBP and CRP were serially measured from day(d)1 (onset of sepsis) to d14 in parallel
with clinical data until d28. Predictive value and correlation of LBP and CRP were analyzed by Receiver Operating
Characteristic (ROC) curve analysis and Pearson’s test, respectively.
Main Results: LBP and CRP showed the highest levels on d2 or d3 after the onset of sepsis with no significant difference
between survivors and nonsurvivors. Only at d7, nonsurvivors had significantly (p=.03) higher levels of CRP than survivors.
Accordingly, in ROC analysis, concentration of CRP and LBP on d7 poorly discriminated survivors from nonsurvivors (area
under curve=.62 and .55, respectively) without significant difference between LBP- and CRP-ROC curves for paired
comparison. LBP and CRP plasma levels allocated to quartiles correlated well with each other (r
2=.95; p=.02). Likewise,
changes in plasma concentrations of LBP and CRP from one observation to the next showed a marked concordance as both
parameters concomitantly increased or decreased in 76% of all cases.
Conclusions: During the first 14 days of postoperative sepsis, LBP plasma concentrations showed a time course that was
very similar to CRP with a high concordance in the pattern of day-to-day changes. Furthermore, like CRP, LBP does not
provide a reliable clue for outcome in this setting.
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Introduction
Sepsis is still the main cause of death in surgical intensive care
units with a continuously increasing incidence and a mortality rate
ranging from 30% to 60% depending on sepsis severity and the
days of hospital stay [1,2]. Therefore, both an early diagnosis and
prognosis of sepsis are of utmost importance to control efficacy of
antibiotic and surgical therapy, to manage further diagnostics and
interventions and to optimize cost containment. To identify
patients that are at high risk to succumb to sepsis, however, is
difficult, due to a vast variety of influencing factors (e.g. age,
underlying disease, co-morbidity, focus and type of infection,
readiness and adequacy of therapy). Clinical and routine
labarotory signs, like fever and leukocytosis, respectively, as well
as clinical scores like APACHE II and SAPS II are not always
helpful for outcome prediction [3,4]. Therefore biomarkers that
are released during the inflammatory response, like PCT, IL6 and
CRP, have been investigated and suggested as useful parameters to
determine the outcome of septic patients [4,5,6,7,8,9,10,11].
However, there is no generally accepted marker for monitoring
the evolution of sepsis. More recently, Lipopolysaccharide-binding
protein (LBP) has been proposed as a sensitive marker for bacterial
infection [12,13] and possibly useful follow-up parameter in
detection and resolution of sepsis [14,15]. Like CRP, LBP is an
acute phase protein, that is produced by hepatocytes as well as
epithelial cells of the intestine and the lungs [16,17] after induction
by interleukin-(IL)-6 and IL-1, and a key participant in the innate
immune response to Gram-negative, Gram-positive bacterial and
fungal infections. Due to a binding site for the lipid A moiety of
Lipopolysaccharide (LPS) from Gram-negative bacteria [18], LBP
facilitates the transfer of LPS to the membrane-bound CD14-
receptor [19]. Thereby low concentrations of LBP enhance LPS-
induced cell activation and may induce inflammation at local sites
of infection, whereas higher concentrations of LBP can neutralize
LPS-induced activation and may prevent systemic inflammation
[20]. LBP is constitutively present in human plasma at low
concentrations (3–15 mg/ml) [21] and can increase up to 200 mg/
ml during the acute phase response [22,23]. There are several
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critically ill patients with sepsis and infection, however, in part with
inconsistent result [15,22,23,24]. C-reactive protein (CRP) is a well
established parameter to detect local infection and has also been
used for many years in monitoring the inflammatory response to
sepsis [15,22,24].
In the present study we compared the time course of LBP and
CRP plasma levels in survivors and nonsurvivors during the first
14 days of postoperative sepsis and examined the performance of
both markers regarding outcome prediction. Moreover, we studied
whether LBP can provide useful information in addition to CRP
and determined the correlation of LBP and CRP and their
concordance concerning day-to-day changes of plasma concen-
trations.
Materials and Methods
Objectives
We conducted a prospective, observational study at the
University Hospital of Erlangen-Nuernberg, Germany, a 1400-
bed tertiary care hospital involving patients with sepsis, severe
sepsis and septic shock. Surgical adult patients postoperatively
admitted to the interdisciplinary operative ICU (24 bed) after
elective major abdominal or thoracic surgery, were included as
soon as they met the criteria of sepsis, as defined by the
International Sepsis Definitions Conference [25]. Patients were
observed for 28 days from enrollment, or until death or discharge
from the hospital if either occurred before day 28. They were
classified as survivors and nonsurvivors of sepsis according to the
outcome at day 28 after study enrollment. The primary study
endpoint was 28-day mortality from sepsis.
Ethics
The study was approved by the Institutional Ethics Committee
(Ethik-Kommission der Medizinischen Fakulta ¨t der Universita ¨t
Erlangen-Nu ¨rnberg) according to the International Declarations
of Helsinki and Tokyo (approval No.: 3298). For participation in
the study, informed written consent was obtained from all patients,
legal representatives or next of kin.
Study protocol
At time of enrollment, all included patients had to have a
microbiologically confirmed or definite clinical evidence of
infection and at least two of the following criteria of a Systemic
Inflammatory Response Syndrome (SIRS) within a few hours, not
exceeding 24 hours: core body temperature .38.0uCo r,35.6uC;
tachycardia .90 bpm; tachypnea .20 breaths/min or need for
mechanical ventilation; leukopenia (WBC,4000/ml) or leukocy-
tosis (WBC.10000/ml) or more than 10% unsegmented neutro-
phils. At the onset of sepsis, the severity of the patient’s condition
was determined by using Acute Physiology and Chronic Health
Evaluation II (APACHE II) score. Patients who died of causes
clearly not related to sepsis were excluded from outcome analysis
(dropouts). All patients were daily screened for the presence of
clinical and analytical signs of sepsis and, when indicated, blood
cultures, swabs, aspiration or biopsies of suspected sites of infection
were obtained to ensure early identification of causative
microorganisms. Broad spectrum antibiotic therapy was adminis-
tered to all patients as soon as sepsis was suspected and adapted
according to the antibiogram as soon it was obtained. Diagnostic
procedures, e.g. blood gases, laboratory and imaging exams, and
supportive therapy (noradrenalin, dobutamine) were performed as
clinically indicated. None of the patient studied received Activated
Protein C, whereas all patients with septic shock were treated with
low dose corticosteroids as adjunctive therapy.
Measurements and data collection
Within 12 h after study entry, serial, heparinized blood samples
were drawn (Heparin-Monovette, Sarstedt, Nuernbrecht, Ger-
many) via an arterial line for inflammation marker measurements
on day 1 (i.e. onset of severe sepsis), and at 7–8 a.m. on days 2, 3,
5, 7, 10, and 14. In addition, clinical data were recorded daily
during follow-up including demographic data, diagnosis, surgical
intervention, site of infection and results from microbiological
cultures. Plasma was analyzed the same day or stored at 220uC
until further analysis. CRP was measured using a turbidimetric
assay with a detection limit of 1 mg/l. Plasma levels of LBP were
measured using a semiautomated, chemiluminescent immunoas-
say (Immulite
TM, Siemens Healthcare Diagnostics, Eschborn,
Germany) with an assay sensitivity of 0.2 mg/ml. Trained
laboratory technicians, blinded to the patient’s clinical course,
treatment assignments and outcome of the patients performed all
measurements. Clinicians responsible for the care of the patients
were aware of CRP, but unaware of LBP and the data evaluation.
Statistics
Variables with nominal scale (sex) are described using absolute
and relative frequencies. Kolmogorov-Smirnov test was employed
to verify the normality of distribution of continuous variables. For
univariate description of normally distributed variables, mean
values and standard deviation (SD) are given. For univariate
description of non-normally distributed variables, median with 25–
75 interquartile ranges (boxes) and 5th and 95th percentile
(whiskers) were used. To compare concentrations along time
within groups Kruskal-Wallis analysis of variance followed by
Mann-Whitney U test were applied. Comparisons between
survivors and nonsurvivors were performed by using Mann-
Whitney U test. To correct for multiple testing, Bonferroni
correction was performed. Univariate analysis of predictive
accuracy of CRP and LBP plasma concentrations in discriminat-
ing survivors from nonsurvivors was done by using receiver
operating characteristic (ROC) curves with the area under curve
(AUC) as measure of overall performance. The relationship
between CRP and LBP plasma concentrations were analyzed by
simple linear regression of CRP on LBP after allocating the levels
to quartiles (Q1: 0–25th, Q2: 26th–50th, Q3: 51st–75th, Q4:
76th–100th percentile). Correlation between CRP and LBP levels
transformed to quartile numbers was investigated by Pearson’s
test. P-values of 0.05 or less were considered significant. All
analyses were done using Statistica (version 6.0, StatSoft, Tulsa,
OK, USA) and MedCalc (version 11.1.1, MedCalc Software,
Mariakerke, Belgium).
Results
Sixty consecutive patients meeting the criteria of sepsis, severe
sepsis or septic shock after abdominal or thoracic surgery and
admitted to the interdisciplinary ICU were screened for eligibility.
One patient was excluded from analysis due to death not related to
sepsis (pulmonary embolism). The demographics and clinical
characteristics of the fifty-nine patients that were included in the
per-protocol analysis are shown in Table 1. There were 40 (68%)
survivors (group S) and 19 (32%) nonsurvivors of sepsis (group NS)
28 days after onset of sepsis (day 1) (Figure 1). The two groups had
similar demographic and clinical characteristics including site of
infection, surgical intervention and identified microorganisms.
Both in S and NS, Gram-negative bacteria were identified in less
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sepsis, as judged by the APACHE II score, was similar both in
sepsis survivors and nonsurvivors. For the entire population
studied, the APACHE II score at day 1 was 22.566.3 (mean 6
SD) due to a high percentage (95%) of patients with severe sepsis
and septic shock on admission. Within 3 days after admission, all
patients enrolled were intubated, mechanically ventilated and
received catecholamines (dobutamine, noradrenalin) to keep the
sytemic blood pressure above 90 mmHg., and thus fulfilled the
criteria of septic shock. All deaths were due to multiple organ
failure.
Time course of LBP and CRP plasma concentrations
during the first 14 days of sepsis
Plasma levels of LBP and CRP serially measured at day 1 (onset
of sepsis), d2, d3, d5, d7, d10 and d14 are depicted in Figure 2A–
B. During the first week of sepsis, both CRP and LBP showed the
highest plasma levels at d2 or d3 after onset of sepsis with median
values above 100 mg/L and 50 mg/L, respectively, in both
groups (S and NS). During the first five days of sepsis, there was no
significant difference between S and NS in both plasma markers.
Toward the end of the first week, we observed a decline in LBP
and CRP to lower levels that was more pronounced in survivors
than in nonsurvivors. With a nadir at d5 in nonsurvivors, LBP and
CRP levels started to markedly increase within the second week.
Surprisingly, we also found moderately increasing LBP and CRP
levels from d7 to d14 in the surviving group. In contrast, there was
no significant change in white blood count (WBC) during this time
period (1536366860/ml at day 7; 1595966264/ml at day 10;
1108263098/ml at day 14; WBC 6 SD). The only significant
difference between S and NS during the entire study period was
observed for CRP at d7 (p=.049).
Performance of LBP and CRP to predict outcome and
correlation of both markers
To evaluate the predictive accuracy of CRP and LBP plasma
levels in discriminating survivors from nonsurvivors, ROC analysis
was performed. During the first 5 days of sepsis, median plasma
concentrations of LBP and CRP were even higher in S than in NS
and did not discriminate both groups as assessed by ROC analysis
(AUC,.55; data not shown). Only at day 7, CRP levels poorly
discriminated S from NS with an area under the curve (AUC) of
0.63 (CI 0.49–0.76; p=0.16), whereas LBP again failed to
discriminate both groups (AUC=0.55, CI 0.40–0.69; p.0.5)
(Figure 3). Pairwise comparison of ROC curves of LBP and CRP
showed no significant difference between areas under curve
(p=0.50).
For determination of the relationship between LBP and CRP,
plasma levels were transformed to quartile numbers (1–4)
according to the quartile (Q1: 0–25th, Q2: 26th–50th, Q3: 51st–
75th, Q4: 76th–100th percentile) they were located, in order to
account for a variable degree of association between LBP and
CRP. Quartile numbers of LBP and CRP plasma concentrations
that were obtained from a patient at the same time point were
found to highly correlate with each other (r
2=.95, p=.02), i.e. the
higher the quartile a patient’s CRP level was assigned to, the
higher the quartile of its concomitant LBP level (Figure 4).
Moreover, the mean quartile number of LBP associated with the
3rd and 4th CRP quartile, respectively, was significantly above
that of the 1st CRP quartile. In addition, we also studied whether a
change (increase or decrease) of CRP from one time point to the
next following was associated with a concomitant change of the
LBP concentration in the same direction. There was a strong
Figure 1. Kaplan-Meier Plots showing the survival rate of the
entire study group during 28 days of observation. Before day 14,
only 6 (10%) out of 59 patients died. In the third and forth week after
onset of sepsis, 7 (12%) and 6 (10%) patients died, respectively. Forty
(68%) out of 59 patients survived day 28.
doi:10.1371/journal.pone.0023615.g001
Table 1. Demographic and (post)operative characteristics of
patients enrolled in the study.
Survivors Nonsurvivors
(n=40) 68% (n=19) 32%
Age (yrs) 64.1616.2 61.5618.5 p.0.5
Weight (kg) 78.462.4 80.662.1 p.0.5
Height (cm) 173.369.4 171.169.1 p.0.5
Gender (%) male 75 74
APACHE II score (day1) 20.566.6 23.565.9 p=.098
Cause of death
MODS n.a. 19
Surgery
Esophagus 8 (20%) 3 (16%)
Gastrointestinal 17 (43%) 9 (47%)
Liver/Gall 4 (10%) 2 (11%)
Pancreas 4 (10%) 1 (5%)
Other 7 (18%) 4 (21%)
Site of Infection
Lung only 7 (18%) 4 (21%)
Abdomen only 10 (25%) 5 (26%)
Combined 19 (48%) 8 (42%)
Other 4 (10%) 2 (11%)
Identified Organisms
Bacteria Gram positive only 11 (28%) 5 (26%)
Bacteria Gram negative only 15 (38%) 8 (42%)
Polymicrobial 10 (25%) 5 (26%)
Other (unidentified, fungi only) 4 (10%) 1 (5%)
Values are mean 6 SD or actual numbers (percentages) of postoperative
patients with sepsis (per protocol analysis, n=59), assigned to survivors (n=40)
or nonsurvivors (n=19) according to their survival on day 28 after onset of
sepsis. Indicated surgery refers to the main organ operated prior to study
enrollment. n.a. not applicable. There were no significant differences between
the groups.
doi:10.1371/journal.pone.0023615.t001
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the associated LBP changes for all patients and time points studied
during the first 14 days of sepsis (Table 2). In 76% of all cases,
where CRP concentrations increased or decreased from one time
point to the next, LBP behaved accordingly. Only twelve percent
of all CRP increases and 12 percent of all decreases, from one
observation day to the next, were not accompanied with a
simultaneous change of LBP concentration in the same direction.
Discussion
The present study demonstrates that LBP and CRP plasma
concentrations have a similar time course during the first 14 days
of postoperative sepsis: First an increase with a maximum around
the first or second day after onset of sepsis followed by a decrease
in the first week and a re-increase in the second week. Plasma
concentrations of both LBP and CRP in nonsurvivors did not
significantly differ from survivors and were rather lower than those
in survivors during the first five days of sepsis. Similar findings
have been reported on LBP by other investigators, showing either
no difference between S and NS of severe sepsis [15,24] and
critically ill patients [22], respectively, or significantly higher LBP
levels in survivors than in nonsurvivors of severe sepsis at study
entry [23]. In a mixed study population with SIRS, sepsis and
severe sepsis, the maximum LBP concentration during the first 3
days in the ICU was found to moderately discriminate between S
and NS [24]. However, as LBP plasma levels have been shown to
correlate with sepsis severity [12,22], differences in LBP plasma
concentrations between S and NS are to be expected in
inhomogeneous populations with different levels of severity.
Figure 2. A. Time course of CRP plasma concentrations in
postoperative septic patients during the first 14 days of sepsis
(n=59). Data are presented as box-plots (open, survivors, n=40;
hatched, nonsurvivors, n=19) depicting the lower and upper quartiles
(boxes) and the 5th and 95th percentile (whiskers). * p,.05 for
intergroup comparison of septic survivors vs. nonsurvivors. B. Time
course of LBP plasma concentrations in postoperative septic patients
during the first 14 days of sepsis (n=59). Data are presented as box-
plots (open, survivors, n=40; hatched, nonsurvivors, n=19) depicting
the lower and upper quartiles (boxes) and the 5th and 95th percentile
(whiskers). * p,.05 for intergroup comparison of septic survivors vs.
nonsurvivors.
Figure 3. Receiver operating characteristic (ROC) curves of CRP
and LBP on day 7 after onset of sepsis analyzed for prediction
of survival on day 28. The area under curve (AUC) of CRP and LBP, a
measure of predictive accuracy, was 0.63 (CI 0.48–0.76; p=0.16) and
0.55 (CI 0.40–0.69; p.0.5), respectively.
doi:10.1371/journal.pone.0023615.g003
Figure 4. Relationship between CRP and LBP plasma concen-
trations after transformation to quartiles (Q1–Q4). Data repre-
sent the regression of CRP on LBP quartiles and the correlation between
CRP and LBP (r
2=0.95, p=0.16). For every CRP quartile, mean, lower
and upper quartile (boxes) and standard deviation (whiskers) of the LBP
quartiles are shown. * p,.05 for intergroup comparison of the mean of
LBP quartiles associated with Q3 and Q4 vs. Q1 of CRP.
doi:10.1371/journal.pone.0023615.g004
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nonsurvivors increased above that of survivors only from day 7 to
day 14, but not in the first three days, may rather be due to the
relatively good homogeneity of our study group regarding sepsis
severity at study entry.
In the second week of sepsis, we found a marked re-increase of
LBP and CRP in the nonsurviving group most likely as part of an
inflammatory response to a recurrent or unresolved infection.
Surprisingly, we also observed a moderate, but noticeable rise in
LBP and CRP plasma levels from day 7 to day 14 in patients of the
surviving group without any evidence for a new or recurrent
infection. That is, we neither observed clinical and radiological
signs nor significant changes in body temperature (data not shown)
or white blood count during the second week in group S. We
therefore assume that in these patients LBP and CRP unspecifi-
cally increased due to stressful maneuvers imposed upon them in
the ICU (i.e. end of analgosedation, 9 and extubation, vigorous
physiotherapy etc.). Therefore, a moderate re-increase in LBP or
CRP plasma concentration in the second week of sepsis is no
reliable indicator of a recurrent infection in this setting of
postoperative sepsis.
Due to a broad overlap between S and NS both in LBP and
CRP plasma concentrations during the first 5 days of sepsis, their
predictive accuracy for mortality (at day 28) as assessed by ROC-
analysis was very poor (AUC,.55). Similar findings were reported
for LBP (AUC=.53) and CRP (AUC=.56) plasma concentrations
on ICU admission in a heterogeneous population of postoperative
patients with SIRS, sepsis or septic shock [24]. Likewise, Prucha
et al [22] found no significant difference in LBP concentrations
between survivors and nonsurvivors at study entry in a mixed
group of critically-ill patients. In a more recent study on patients
with severe sepsis, Villar et al. confirmed this result for LBP at
study entry (AUC: 0.57, CI: 0.52–0.71, p=.173). However,
48 hours later, LBP plasma concentration was found a better
outcome predictor (AUC: 0.71, CI: 0.61–0.80, p,.0001) [15].
Although the population of that study seems to be quite
comparable to our study regarding sepsis severity (mean APACHE
II score 23.2 vs. 22.5) and mortality (40% vs. 32%), there may be
two relevant differences in the populations that would explain why
we could not reproduce Villar’s finding that LBP at 48 h is a good
predictor of outcome: First, we studied only postoperative septic
patients, whereas Villar’s study seemed to include medical patients
with sepsis and pneumonia as well. As shown for CRP and other
acute phase proteins [26], postoperative LBP plasma concentra-
tions could be unspecifically elevated due to surgical trauma. In
the present study, therefore, possible differences between S and NS
in the LBP levels 48 h after onset of sepsis might have been
blurred by an unspecific response to surgery.
Second, in contrast to our study, where only 2 (3%) of the
patients had Adult Respiratory Distress Syndrome (ARDS), 55%
of Villar’s patient population suffered from ARDS [15]. Those
ARDS patients as well as the nonsurvivors were reported to have
the highest values of LBP, whereas patients who survived and
those who did not develop ARDS had significantly lower LBP
levels at 48 h [15]. As previously has been shown, LBP can be
produced by epithelial cells of the lungs under pathophysiological
conditions found in ARDS in response to inflammatory mediators
(IL-1, IL-6 and TNF alpha) [16]. Therefore, in Villar’s study, the
difference in LBP levels between NS and S may rather be
attributed to a higher percentage of ARDS patients in the
nonsurviving group and not merely to sepsis.
Our finding that CRP plasma levels either did not (d1–d5) or
only poorly (AUC=0.63 at d7) discriminate S from NS during the
first week of sepsis, is in good agreement with the studies of Villar,
Sakr and other previous investigations [10,15,24]. Furthermore,
for the entire population studied and across all observation time
points, we found a strong correlation between the quartile
numbers LBP and CRP plasma concentrations were assigned to
(r
2=.95, p=.02). This result is not unexpected, since CRP and
LBP are both acute phase proteins, induced by the same
inflammatory mediators, and correlate significantly well with each
other (r=.71, p,.001) in an experimental LPS-inhalation study in
healthy volunteers [27]. A strong correlation (r=0.84, p,.0001)
between LBP and CRP was also found by Gaini et al. in patients
with suspected community-acquired infection and sepsis [12] and
in surgical ICU patients with sepsis syndromes (r
2=.36, p,.001)
[24]. Likewise, a significant, but less strong correlation (r=.54,
p=.002) between LBP and CRP was described in patients with
sepsis and septic shock [22].
Although the liver is the main source of both acute phase
proteins, under certain pathophysiological conditions, CRP can
also be produced by epithelial cells of the kidneys [28] as well as
LBP can be released by epithelial cells of the intestine and the
lungs [16]. Therefore, the degree of correlation between CRP and
LBP may vary, dependent on the individual contribution of
extrahepatic sources according to the site of infection.
More often than the absolute plasma concentration of a
biomarker, its time course is used to judge the resolution of sepsis.
We therefore questioned, whether a change in LBP plasma level
from one observation day to the next occurs in parallel with CRP.
Our results show that across all time points and all patients
studied, more than three out of four changes in the LBP
concentration from one to the next observation day were
accompanied with a simultaneous change in the CRP level in
the same direction. Although LBP is known to significantly
increase in plasma approximately 12 hrs ahead of CRP in
Table 2. Association of CRP and LBP changes in the plasma concentration from one time point of observation to the other during
14 days after onset of sepsis.
CRP increase
from one to the next observation
CRP decrease
from one to the next observation
LBP increase
from one to the next observation
28%
(67/242)
12%
(29/242)
LBP decrease
from one to the next observation
12%
(29/242)
48%
(117/242)
Data represent the percentage of increases and decreases in CRP levels from one to the next observation that were accompanied by concomitant increases or decreases
in LBP levels over all patients and time points measured. Changes of CRP and LBP levels in the same direction (concordance) occurred in 76%, changes in the opposite
direction (discordance) in 24% of all cases.
doi:10.1371/journal.pone.0023615.t002
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some earlier information regarding the development of sepsis, does
not really provide an advantage in a clinical setting where
biomarkers are determined in 24-hour intervals. Therefore, our
finding does not support the notion that assessment of LBP has
significant advantage over CRP in this context. LBP and CRP
plasma concentrations, assessed in intervals of 24 hours and more,
rather show a very similar kinetics in the course of sepsis. Given
the lower costs and the long-term clinical experience with CRP
measurements, we do not consider LBP as a useful biomarker for
the monitoring of sepsis in patients post surgery.
Our study has several strengths. First, according to Randolph
et al. [30], our study population was a representative sample of
critically ill adult patients and sufficiently homogenous with respect
to prognostic outcome, since all patients had sepsis after major
surgery and were studied from day 1 of sepsis. Second, the
unbiased and well-defined endpoint used was mortality directly
related to multiple organ dysfunction due to severe sepsis within
the first 28 days.
However, some limitations also merit consideration: The
prognostic accuracy of LBP and CRP may have been negatively
influenced in our study population, because LBP and CRP are
frequently unspecifically elevated after major surgery to levels
comparable to those seen in sepsis. Therefore, in septic patients
not subjected to surgical trauma, e.g. in medical patients, LBP and
CRP may provide a better prognostic accuracy. In addition,
although statistically controlled, we cannot completely exclude
small sample size effects in our study population. Moreover, LBP
and CRP may be clinically useful in critically ill neonates and
children, where LBP has a high diagnostic accuracy to
differentiate sepsis from non-infectious SIRS [14,31].
In conclusion, our study demonstrates that LBP and CRP
plasma concentrations are well correlated with each other and
change concordantly in the course of sepsis. Furthermore, LBP
and CRP plasma levels have quite the same predictive value and
are neither suitable to monitor resolution of sepsis nor sufficiently
reliable to detect a recurrent infection during the first 14 days of
sepsis in adult postoperative patients.
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